Keine Internetverbindung – die gespeicherte Version der Seite wird angezeigt.

Alterity Therapeu…

AUAUD
← Zum Screener
AU:ATHUS:PRNAF

Alterity Therapeutics Ltd (US:PRNAF) — Biotechnology: Pharmaceutical Preparations. Anzahl der Börsen, an denen die Aktien des Unternehmens gehandelt werden: 2. Auf dieser Seite: Kurs und Chart, Dividenden, größte Aktionäre und Entwicklung der Aktienanzahl.

Über das Unternehmen

Website
alteritytherapeutics.com
Sektor
Health Care · Biotechnology: Pharmaceutical Preparations
Hauptsitz
MELBOURNE, Australia
CEO
David A. Stamler
Mitarbeiter
11
Ausstehende Aktien
217.51 Mio. Stand 2026-06-30
Streubesitz
171.39 Mio.
Marktkapitalisierung
81.28 Mio. AUD
Insider
7.91%
Institutionelle Anleger
17.98%
Branche (SIC)
Pharmaceutical Preparations
Beschreibung

Alterity Therapeutics Limited is engages in research and development of Parkinsonian and neurodegenerative disorders, including Multiple System Atrophy (MSA) and Parkinson's disease. The company's lead drug candidate is ATH434, a small molecule drug candidate that has completed Phase II clinical trial for the treatment of Parkinson's disease. It is also developing ATH434-201, which is in Phase II clinical trial to treat multiple system atrophy early stage; and ATH434-202 that is in Phase II clinical trial to treat multiple system atrophy, as well as bioMUSE, biomarkers of progression in multiple system atrophy. The company also operates drug discovery platform that generates patentable chemical compounds to treat the underlying pathology of neurological diseases. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is based in Melbourne, Australia.

Börsen und Ticker

BörseTickerWährungPreisTyp
AU Australian Securities ExchangeATH primärAUD0.355 -2.74%Stammaktie
US USA StocksPRNAF OTCUSD0.4 +0.00%Stammaktie

Kurs über 3 Monate

Tag mit Kursanstieg Tag mit KursrückgangTag mit der Maus berühren / antippen — Eröffnungs-, Schluss-, Höchst- und Tiefstkurs

Neuigkeiten diese Woche

Noch keine Nachrichten von der Website des Unternehmens.

Anzeige

Größte Anteilseigner

InhaberAnteilAktienBerichtsdatum
Meltzer (Brian Derek) (F…≈49.36%9.42 Mio.2025-11-21
Gozlan (Lawrence) (Direc…≈23.83%4.55 Mio.2025-04-07
Marks (Peter Vincent) (I…≈1.19%227 7042026-08-31
Twin Lakes Capital Manag…0.73%139 2582026-06-30
Morgan Stanley0.33%63 0652026-06-30
Greenleaf Trust0.32%62 0002026-06-30
HB Wealth Management, LL…0.31%58 4602026-06-30
Citadel Advisors Llc0.2%37 5972026-06-30
Kempler (Geoffrey Paul)…≈0.16%30 0002025-11-21
HRT Financial LP0.09%17 2922026-06-30
BNP Paribas Financial Ma…0.05%10 2392026-06-30
Gamma Investing LLC0.01%2 3092026-06-30
Rhumbline Advisers0.01%2 0092026-06-30
Acadian Asset Management…0.01%1 8632026-06-30
Fidelity Concord Street…0.01%1 1552026-05-31
Stamler (David) (Chief E…—91.69 Mio.2025-11-21